XML 14 R3.htm IDEA: XBRL DOCUMENT v3.20.2
Unaudited Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Revenues $ 21,117 $ 14,012 $ 42,329 $ 27,782
Cost of revenues 15,596 10,248 31,768 22,441
Gross margin 5,521 3,764 10,561 5,341
Operating expenses:        
Research and development 2,719 2,398 5,218 4,871
Selling, general and administrative 5,887 5,400 11,524 10,655
Amortization of acquisition-related intangibles 121 85 242 170
Total operating expenses 8,727 7,883 16,984 15,696
Operating loss (3,206) (4,119) (6,423) (10,355)
Change in fair value of warrants 1,145 4,092
Interest income, net 161 335 320 840
Other (expense)/income, net (476) 1,520 (646) 976
Loss before income tax expense (3,521) (1,119) (6,749) (4,447)
Income tax expense (benefit) 191 (294) 380 (83)
Net loss $ (3,712) $ (825) $ (7,129) $ (4,364)
Net loss per common share        
Basic (in dollars per share) $ (0.17) $ (0.04) $ (0.33) $ (0.21)
Diluted (in dollars per share) $ (0.17) $ (0.10) $ (0.33) $ (0.40)
Weighted average number of common shares outstanding        
Basic (in shares) 21,860 20,656 21,775 20,586
Diluted (in shares) 21,860 20,723 21,775 20,736